Cordyceps Sunshine Biotech Holdings RAJAF Ratios (2020-2025)

OTC RAJAF

$9.18 +0.00 (+0.00%)

At close: Aug 19, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Dec2020	Dec2021	Dec2022	Sep2023	Dec2023	Dec2024	Dec2025
Profitability
Gross Margin (Quarter)					258.74%
EBT Margin (Quarter)					26.44%
EBIT Margin (Quarter)					38.18%
EBITDA Margin (Quarter)					38.18%
Operating Margin (Quarter)					38.18%
FCF Margin (Quarter)					-1,652.05%
Efficiency
Inventory Average (Quarter)		0.58M	0.40M	0.16M
Assets Average (Quarter)		3.04M	2.68M	1.95M	2.57M	3.99M	4.64M
Invested Capital (Quarter)	1.29M	1.57M	1.39M			0.45M	0.47M
Leverage & Solvency
Interest Coverage Ratio (Quarter)			-0.65		1.50
Debt Ratio (Quarter)	0.60	0.61	0.86	0.23	0.13	0.10	0.10
Times Interest Earned (Quarter)			-0.65		1.50
Valuation
Enterprise Value (Quarter)	-294.00	-0.10M	-0.01M	-0.02M	-0.02M	-0.04M	-0.00M
Return Ratios
Return on Assets (Quarter)				0.00%	0.00%	0.00%

Cordyceps Sunshine Biotech Holdings (RAJAF)

OTC: RAJAF

$9.18 ▲ +0.00 (+0.00%)

Aug 19, 2026 · 4:00 PM EDT